Image (3b0d8e2b B3c4 4a26 A126 420f56734843 01)
Miglustat Capsule
Product Images NDC 70710-2039
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Miglustat (NDC 70710-2039). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Blister-card (3b0d8e2b B3c4 4a26 A126 420f56734843 02)
Carton (3b0d8e2b B3c4 4a26 A126 420f56734843 03)
This text provides information about migLUstat Capsules containing 100 mg per capsule. The package contains 90 capsules in six blister cards of 15 capsules each. It warns that the package is not child-resistant and is for oral use only with active ingredient miglUstat. The storage instructions indicate keeping it at 20°C to 25°C with excursions permitted between 15°C and 30°C. The medicine should be kept out of the reach of children. The capsules' inactive ingredients include magnesium stearate, povidone, and sodium starch glycolate. Additionally, it mentions the ingredients in the capsule shell and provides a code number for reference. The product is a prescription-only pharmaceutical distributed by Zydus Pharmaceuticals (USA) Inc. with manufacturing in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
